Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a climate-smart pregnancy care program prevent stillbirths in a fast-growing city?

NCT ID NCT07751432

Prevention Sponsor: University of Copenhagen Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only This study
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 07, 2026 · Last updated Aug 11, 2026 · Updated 2 times

Summary

This study tests a co-created antenatal care program designed for busy urban clinics in Dar es Salaam, Tanzania, where climate risks like heat, flooding, and pollution add to pregnancy challenges. The program includes guidance for pregnant women and their families, provider training, booklets, and text message reminders. Researchers will compare pregnancy care and outcomes before and after the program is introduced, focusing on whether it reduces stillbirths and improves care quality.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
A co-created antenatal care program including guidance for pregnant women and families, provider training, booklets, and text message support.
What this could lead to
If effective, this program could reduce stillbirths and improve pregnancy care in climate-vulnerable urban settings, offering a model for other low- and middle-income cities.
What could go wrong
This is a pre-post comparison, not a randomized trial, so results may be influenced by other changes over time. The program's success depends on implementation in busy clinics, and outcomes may not generalize to other settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 1,060 people

The number the study aims to enrol. It can still change while the study runs.

Started

Mar 2026

Expected to finish

Dec 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Pregnant women attending antenatal care at participating government health facilities in Temeke District, Dar es Salaam, during the study period. * Able and willing to provide informed consent. Exclusion Criteria: * Women not attending antenatal care at a participating government health facility in Temeke District. * Women who do not provide informed consent. * Individuals otherwise not eligible according to local ethical requirements.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Abortion, spontaneous are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Abortion, Spontaneous hypertension, pregnancy-induced Perinatal Death Stillbirth pregnancy disorder with abortive outcome prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Abortion, spontaneous Hypertension, pregnancy induced Perinatal death Stillbirth

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • 21 Antenatal Care Clinics in Temeke District, Dar es Salaam.

    Dar es Salaam, Temeke District, Tanzania

More trials for these conditions

Other studies related to the condition(s) this trial covers.